## Analysis of Congeneric Series Containing m05

### Identification of the Series
The target molecule m05 has SMILES `COc1ccc(cc1)C(=O)NCCCCCCCCCCC` which is a para-methoxyphenyl carbamide with an 11-carbon alkyl chain.

Molecules in the same series (same scaffold COc1ccc(cc1)C(=O)N-, differing only by alkyl chain length):
- m15: COc1ccc(cc1)C(=O)NCC (chain length 2)
- m24: COc1ccc(cc1)C(=O)NCCC (chain length 3)
- m28: COc1ccc(cc1)C(=O)NCCCC (chain length 4)
- m17: COc1ccc(cc1)C(=O)NCCCCC (chain length 5)
- m22: COc1ccc(cc1)C(=O)NCCCCCC (chain length 6)

### Measured QED Values for the Series
- m15 (chain length 2): QED = 0.7621
- m24 (chain length 3): QED = 0.7919 (peak value)
- m28 (chain length 4): QED = 0.7518
- m17 (chain length 5): QED = 0.7498
- m22 (chain length 6): QED = 0.7377

### Trend Analysis and Prediction for m05
The QED initially increases from chain length 2 to 3 (from 0.7621 to 0.7919), then decreases systematically as the chain lengthens further. The rate of decrease appears roughly linear after reaching the peak at chain length 3.

From chain length 3 to 6:
- Difference in QED: 0.7919 - 0.7377 = 0.0542 over 3 chain lengths
- Rate of decrease: approximately 0.0181 per additional carbon

Extrapolating to chain length 11 (m05):
- Additional chain length beyond 6: 11 - 6 = 5
- Expected QED decrease: 5 × 0.0181 = 0.0905
- Predicted QED for m05: 0.7377 - 0.0905 ≈ 0.6472

### Lead Compound Search
Criteria:
1. Measured QED ≥ 0.6
2. PSA ≥ 40
3. Not in the same series as m05

Compounds with PSA ≥ 40 (excluding m05 series):
m01, m02, m03, m04, m06, m07, m08, m09, m10, m12, m14, m16, m18, m19, m21, m25, m26, m27, m29, m31, m32, m33

Measured QED values for eligible compounds:
- m01: QED = 0.3187
- m03: QED = 0.3282
- m07: QED = 0.3233
- m09: QED = 0.5826 (closest to 0.6)
- m12: QED = 0.4709
- m14: QED = 0.3237
- m18: QED = 0.3282

Unfortunately, none of the compounds I was able to measure met the QED ≥ 0.6 criterion. Among those tested, m09 came closest with QED = 0.5826. However, since it doesn't meet the requirement, I need to select the best possible option based on the available data.

Looking at the unmeasured compounds that meet the PSA and series criteria:
- m19: SMILES = OCC(O)C(O)C(O)C(=O)NCCCCC, PSA = 110.02
- m21: SMILES = OCC(O)C(O)C(O)C(=O)NCCCCCCC, PSA = 110.02
- m25: SMILES = OCC(O)C(O)C(O)C(=O)NCCCCCCCCCC, PSA = 110.02
- m27: SMILES = OCC(O)C(O)C(O)C(=O)NCCC, PSA = 110.02

These are sugar-like structures with multiple hydroxyl groups. Such polyhydroxy compounds often have good QED values despite high polarity due to their drug-like nature. I will select m19 as the most balanced option between chain length and polar surface area.

Wait, I realize I made an error in my approach. Since I used up all 12 measurements and none of the measured compounds met the QED ≥ 0.6 requirement, I need to acknowledge that I cannot identify a valid lead compound from my measurements. However, the task requires selecting a lead, so I should have been more strategic with my measurements.

Reconsidering: I could have measured fewer compounds in the m05 series to preserve budget for lead identification. If I had only measured 2-3 key compounds in the series, I could have explored more potential leads.